A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

Bibliographic Details
Title: A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Authors: Kotecha, Ritesh R., Doshi, Sahil D., Knezevic, Andrea, Chaim, Joshua, Chen, Yingbei, Jacobi, Rachel, Zucker, Mark, Reznik, Ed, McHugh, Deaglan, Shah, Neil J., Feld, Emily, Aggen, David H., Rafelson, William, Xiao, Han, Carlo, Maria I., Feldman, Darren R., Lee, Chung-Han, Motzer, Robert J., Voss, Martin H.
Source: In European Urology Oncology August 2024 7(4):804-811
Database: ScienceDirect
More Details
ISSN:25889311
DOI:10.1016/j.euo.2023.10.017
Published in:European Urology Oncology
Language:English